David Alderman: ASH25 is Live
David Alderman, President and CEO at Molekule Consulting, shared on LinkedIn:
”Silence before the field ruptures again.
First thing you see walking into ASH25.
Black letters on white. Lobby reeks of fresh carpet glue.
Four days in Orlando will break frontline logic, erase durability curves, and force every franchise team to rewrite 2026–2030 tonight.
Hematology never sleeps in December.
Everyone else does.
If you’re here, you feel it in your chest already.
If you’re not, pay attention.
What leaves these halls this week will outlive the building.
We are already live in every lineage that pays the bills.
If today’s late-breakers just detonated your 2027 budget, find us before your competitor does.
ASH25 is live.”
All from ASH25 featured in Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies